Anthropic Enters Drug Discovery, Oura Tracks Psychedelics, Life Time Bets on GLP-1s
July 1, 2026: Your daily rundown of health and wellness news, in under 5 minutes.
Today's top stories:
Life Time CEO Bahram Akradi calls GLP-1 threat "a wrong bet," positioning MIORA clinics as companion to treatment as research shows pairing exercise could prevent 50,000 cardiovascular events
Oura joins research initiative providing biometric data to study veterans undergoing psychedelic therapies, adding continuous physiological context to mental healthcare
Anthropic launches Claude Science and internal drug discovery program focused on neglected diseases, using AI directly rather than just…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.